Friday, Apr 19 2024 | Time 20:22 Hrs(IST)
image
Business EconomyPosted at: Oct 18 2021 5:20PM


MSN Labs launches Empagliflozin tablets SGLT2i under brand name 'EMPAONE'

Hyderabad, Oct 18 (UNI) MSN Laboratories Private Limited, India’s leading integrated pharmaceutical company, on Monday announced that it has launched India`s most affordable Empagliflozin tablets (SGLT2i), the promising drug in diabetic management, under the brand name ‘EMPAONE’.
The medicine will cost INR 15.90 and INR 18.90 for each 10 mg and 25 mg tablets respectively, Hyderabad based pharmaceutical company said in a release.
‘EMPAONE’ is intended to provide diabetes patients in need across India with an affordable and accessible therapeutic option.
India being the diabetic capital of the world with over 77 million people suffering from Type 2 diabetes, this medicine will minimize the cost burden on patients and in turn improve compliance.
Launch of EMPAONE assumes a critical role particularly for patients suffering from Type 2 diabetes and who were also affected with Covid-19, as diabetes has been found to be a major comorbidity factor in such cases.
MSN Group commented: “Diabetes, if not effectively managed, can lead to multiple and severe health complications. With cost burden identified as a significant limiting factor for compliance, we are glad to launch ‘EMPAONE’ in a cost-effective manner making the drug available, accessible and affordable to the patients.”
MSN has developed the Active Pharmaceutical Ingredient (API) & the finished dosage formulation (FDF) of EMPAONE at its in-house state-of-the-art R&D center.
The development is fully indigenous right from conceptualization to API development and FDF.
UNI KNR CS 1720
Please log in to get detailed story.
Tags: #MSN Labs launches Empagliflozin tablets SGLT2i under brand name 'EMPAONE'
More News

Amara Raja Infra Wins Greenko’s 700MWp solar project in AP

19 Apr 2024 | 6:41 PM

Hyderabad, Apr 19 (UNI) Amara Raja Infra Private Limited (ARIPL), part of the $1.75 billion Amara Raja Group, on Friday announced it has secured a solar BoS (Balance of System) project of 500MW/700MWp from Greenko.

see more..
Sensex recovers 600 points on heavy buying on last day of week

Sensex recovers 600 points on heavy buying on last day of week

19 Apr 2024 | 5:34 PM

Mumbai, April 19 (UNI) Snapping a losing streak of last four sessions, the BSE Sensex on Friday bounced back 599.34 points to close at 73088.33 on expectation of minimal escalation of tension between Israel and Iran.

see more..

19 Apr 2024 | 5:24 PM

Mumbai, Apr 19 (UNI) IT major Wipro on Friday reported 7.80% year-on-year dip in consolidated net profit at Rs 2,834.6 crore for January-March quarter (Q4) of the financial year 2023-24.

see more..
Rupee up 8 paise against USD

Rupee up 8 paise against USD

19 Apr 2024 | 5:05 PM

Mumbai, April 19 (UNI) The Rupee on Friday ended positive at 83.47, rising 8 paise against the USD on selling US Dollar by bankers and exporters, dealers at the Foreign exchange said.

see more..

Kottayam-Kochi Rubber Market rates

19 Apr 2024 | 5:02 PM

Kottayam, April 19 (UNI) Following were the Rubber Market rates announced by the Rubber Board here on Friday per quintal.

see more..
image